Insulin-Producing Mini Stomachs

Scientists grow gastric organs in vitro that can restore insulin production when transplanted into mice.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A section of the mini stomach with cell nuclei (blue), insulin-producing cells (red), and gastric stem and progenitor cells (green)CHAIYABOOT ARIYACHET (VIA EUREKALERT)In type I diabetes, insulin-producing beta cells in the pancreas are destroyed by the immune system, reducing an individual’s capacity to regulate glucose levels in the blood. Now a team led by researchers at Harvard has reported a new method to create personalized insulin-producing organs in vitro, which can restore normal blood-glucose levels when transplanted into mice with the disease. The findings were published last week (February 18) in Cell Stem Cell.

“In various disease states, you have a constant loss of beta cells,” study coauthor Qiao Zhou of Harvard University said in a statement. “We provide, in principle, an advantage to replenish those.”

Cells in a region called the pylorus, between the stomach and the small intestine, frequently regenerate and also show several similarities in gene expression to beta cells. When the researchers engineered mice that expressed three genes known to promote beta cell production, they found that these pylorus cells were converted into insulin-secreting cells, and could restore normal glucose levels in the blood.

“We looked all over, from the nose to the tail of the mouse,” said Zhou in the statement. “We discovered, surprisingly, that some of the cells in the pylorus region of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies